Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin

Journal of Clinical Investigation

Volumn 114, Issue 8, 2004, Pages 1128-1135

  Ichihara, Atsuhiro ^a   Hayashi, Matsuhiko ^a   Kaneshiro, Yuki ^a   Suzuki, Fumiaki ^b,c   Nakagawa, Tsutomu ^b   Tada, Yuko ^a   Koura, Yukako ^a   Nishiyama, Akira ^d   Okada, Hirokazu ^e   Uddin, M Nasir ^b   Nabi, A H M Nurun ^c   Ishida, Yuichi ^f   Inagami, Tadashi ^g   Saruta, Takao ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Fac of Applied Biological Sciences   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d KAGAWA UNIVERSITY   (Japan)

^e SAITAMA MEDICAL UNIVERSITY   (Japan)

^f Prevaqol Co   (Japan)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRORENIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; HISTOLOGY; HYPERGLYCEMIA; KIDNEY; METABOLIC ACTIVATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

EID: 9644283069     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI21398     Document Type: Article

References (35)

1. Luetscher, J.A., Kraemer, F.B., Wilson, D.M., Schwartz, H.C., and Bryer-Ash, M. 1985. Increased plasma inactive renin in diabetes mellitus: a marker of microvascular complications. N. Engl. J. Med. 312:1412-1417.
2. Deinum, J., et al. 1999. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia. 42:1006-1010.
3. Véniant, M., et al. 1996. Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J. Clin. Invest. 98:1966-1970.
4. Peters, J., et al. 2002. Functional significance of prorenin internalization in the rat heart. Circ. Res. 90:1135-1141.
5. Suzuki, F., et al. 2003. Human prorenin has "gate and handle" regions for its non-proteolytic activation. J. Biol. Chem. 278:22217-22222.
6. Maru, I., Ohta, Y., Murata, K., and Tsukada, Y. 1996. Molecular cloning and identification of N-acyl-D-glucosamine 2-epimerase from porcine kidney as a renin-binding protein. J. Biol. Chem. 271:16294-16299.
7. Van-Kesteren, C.A.M., et al. 1997. Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension. 30:1389-1396.
8. Admiraal, P.J.J., et al. 1999. Uptake and proteolytic activation of prorenin by cultured human endothelial cells. J. Hypertens. 17:621-629.
9. Nguyen, G., et al. 2002. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 109:1417-1427. doi:10.1172/JCI200214276.
10. deCavanagh, E.M.V., et al. 2001. Enalapril attenuates oxidative stress in diabetic rats. Hypertension. 38:1130-1136.
11. Onozato, M.L., Tojo, A., Goto, A., Fujita, T., and Wilcox, C.S. 2002. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int. 61:186-194.
12. Hayashi, M., Senba, S., Saito, I., Kitajima, W., and Saruta, T. 1983. Changes in blood pressure, urinary kallikrein, and urinary prostaglandm E2 in rats with streptozotocin-induced diabetes. Naunyn Schmiedebergs Arch. Pharmacol. 322:290-294.
13. Zimpelmann, J., et al. 2000. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int. 58:2320-2330.
14. Vallon, V., Wead, L.M., and Blantz, R.C. 1995. Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction. J. Am. Soc. Nephrol. 5:1761-1767.
15. Kennefick, T.M., Oyama, T.T., Thompson, M.M., Vora, J.P., and Anderson, S. 1996. Enhanced renal sensitivity to angiotensin actionc in diabetes mellitus in the rat. Am. J. Physiol. 271:F595-F602.
16. Campbell, D.J., Kelly, D.J., Wilkinson-Berka, J.L., Cooper, M.E., and Skinner, S.L. 1999. Increased bradykinin and "normal" angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats. Kidney Int. 56:211-221.
17. Everett, A.D., et al. 1992. Renin and angiotensinogen expression during the evolution of diabetes. Hypertension. 19:70-78.
18. Kalinyak, J.E., et al. 1993. The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat. J. Am. Soc. Nephrol. 4:1337-1345.
19. Choi, K.C., et al. 1997. Alterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin-induced diabetic rats. Kidney Int. 52(Suppl.):S23-S27.
20. Zhang, S.-L., et al. 1999. Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int. 55:454-464.
21. Anderson, S., Jung, F.F., and Ingelfinger, J.R. 1993. Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am. J. Physiol. 265:F477-F486.
22. Leehey, D.J., Song, R.H., Alavi, N., and Singh, A.K. 1995. Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes. 44:929-935.
23. Song, R.H., Singh, A.K., and Leehey, D.J. 1999. Decreased glomerular proteinase activity in the streptozotocin diabetic rat. Am. J. Nephrol. 19:441-446.
24. Lewis, E.J., et al. 2001. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345:851-860.
25. Brenner, B.M., et al. 2001. Effects of losartan on renal and cardiovascular outcomes in patients wich type 2 diabetes and nephropathy. N. Engl. J. Med. 345:861-869.
26. Takii, Y., Figueiredo, A.F.S., and Inagami, T. 1985. Application of immunochemical methods to the identification and characterization of rat kidney inactive renin. Hypertension. 7:236-243.
27. El-Nahas, A.M., Bassett, A.H., Cope, G.H., and Carpentier, J.E. 1991. Role of growth hormone in the development of experimental renal scarring. Kidney Int. 40:29-34.
28. Kalluri, R., Shield, C.F., Todd, P., Hudson, B.G., and Neilson, E.G. 1997. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J. Clin. Invest. 99:2470-2478.
29. Inagami, T., Murakami, T., Higuchi, K., and Nakajo, S. 1991. Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Am. J. Hypertens. 4:15S-22S.
30. Iwai, N., Inagami, T., Ohmichi, N., and Kinoshita, M. 1996. Renin is expressed in rat macrophage/ monocyte cells. Hypertension. 27:399-403.
31. Hirota, N., Ichihara, A., Koura, Y., Hayashi, M., and Saruta, T. 2002. Phospholipase D contributes to transmural pressure control of prorenin processing in juxtaglometular cell. Hypertension. 39:363-367.
32. Kobori, H., et al. 1997. Thyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system. Am. J. Physiol. 272:E227-E232.
33. Nishiyama, A., Seth, D.M., and Navar, L.G. 2002. Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J. Am. Soc. Nephrol. 13:2207-2212.
34. Naito, Y., Tsujino, T., Fujioka, Y., Ohyanagi, M., and Iwasaki, T. 2002. Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats. Hypertension. 40:827-833.
35. Wasselius, J., Wallin, H., Abrahamson, M., and Ehinger, B. 2003. Cathepsin B in the rat eye. Graefe's Arch. Clin. Exp. Ophthalmol. 241:934-942.